STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
- Ovarian Cancer
- Exercise - Physical Activity
- +2 more
- Rochester, MinnesotaMayo Clinic
2021-10-28
Oct 28, 2021T
Not yet recruiting
- Ovarian Cancer
- +3 more
- (no location specified)
2022-03-02
Mar 2, 2022J
Recruiting
- Advanced Ovarian Cancer
- Fujian, ChinaFujian Cancer Hospital
2021-05-11
May 11, 2021M
Recruiting
- Ovarian Cancer
- +5 more
- Prehabilitation
- New York, New YorkMemorial Sloan Kettering Cancer Center
2022-03-09
Mar 9, 2022A
Recruiting
- Advanced Ovarian Cancer
- 2X-121
- 2X-121 DRP®
- Boston, Massachusetts
- +1 more
2022-03-21
Mar 21, 2022I
Recruiting
- Ovarian Cancer
- Intraperitoneal Chemotherapy
- Intraperitoneal chemotherapy during surgery
- Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
2022-03-11
Mar 11, 2022T
Recruiting
- Ovarian Cancer
- Hong Kong, Hong KongThe University of Hong Kong
2021-09-27
Sep 27, 2021S
Not yet recruiting
- Ovarian Cancer
- +2 more
- Primary debulking surgery
- +2 more
- Shanghai, ChinaZhongshan Hospital, Fudan University
2022-01-17
Jan 17, 2022A
Not yet recruiting
- Ovarian Cancer
- +2 more
- Carboplatin
- +3 more
- (no location specified)
2021-08-10
Aug 10, 2021C
Not yet recruiting
- Ovarian Cancer
- DP303c injection
- Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
2021-03-30
Mar 30, 2021D
Recruiting
- Ovarian Cancer
- +3 more
- Enhanced Usual Care (EOC)
- REVITALIZE ACT Intervention
- Boston, Massachusetts
- +1 more
2021-07-12
Jul 12, 2021P
Completed
- Ovarian Cancer
- Tranexamic acid
- 0.9% NaCl solution
- Jönköping, Sweden
- +2 more
2022-01-13
Jan 13, 2022S
Not yet recruiting
- Epithelial Ovarian Cancer
- +3 more
- (no location specified)
2022-01-10
Jan 10, 2022W
Recruiting
- Epithelial Carcinoma, Ovarian
- Neoadjuvant Chemotherapy
- cisplatin i.p.
- Chendu, Sichuan, ChinaWest China Second University Hospital of Sichuan University
2021-08-03
Aug 3, 2021G
Completed
- Ovarian Cancer
- Brussels, Belgium
- +8 more
2021-11-07
Nov 7, 2021V
Completed
- Ovarian Cancer
- Vejle, DenmarkDepartment of Oncology, Vejle Hospital
2020-11-26
Nov 26, 2020V
Recruiting
- Advanced Solid Tumor
- Ovarian Cancer
- Neratinib 160 mg
- +7 more
- Richmond, VirginiaVirginia Commonwealth University
2022-03-02
Mar 2, 2022L
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer - 2006
Completed
- Ovarian Cancer
- 90Y-hu3S193
- 111In-hu3S193
- New York, New YorkMemorial Sloan-Kettering Cancer Center
2021-11-23
Nov 23, 2021I
Completed
- Ovarian Cancer
- Functional Imaging previous the second course
- Functional Imaging previous the surgery
- Bordeaux, Gironde, FranceInstitut Bergonié
2021-03-25
Mar 25, 2021E
Terminated
- Breast Cancer Female
- +2 more
- Nivolumab
- Ipilimumab
- Bronx, New YorkHoffman Oncology
2021-11-05
Nov 5, 2021J
Recruiting
- Advanced Ovarian Cancer
- Tranexamic Acid
- normal saline
- Shanghai, Shanghai, ChinaShanghai Cancer Center, Fudan University
2021-11-19
Nov 19, 2021W
Not yet recruiting
- Ovarian Neoplasms
- +14 more
- Drug: Anlotinib
- Drug: Carboplatin/Paclitaxel
- (no location specified)
2021-03-17
Mar 17, 2021H
Recruiting
- Advanced Ovarian Cancer
- Multimodal Prehabilitation
- Barcelona, Spain
- +1 more
2021-04-24
Apr 24, 2021Q
Unknown status
- Ovarian Cancer Stage III
- Ovarian Cancer Stage IV
- PET/CT
- Herston, Queensland, Australia
- +1 more
2021-03-08
Mar 8, 2021L
Recruiting
- Ovarian Cancer
- DC vaccination
- Maywood, IllinoisLoyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
2021-04-23
Apr 23, 2021